FF-10501-01

· Fujifilm Pharmaceuticals U.S.A., Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FF-10501-01, covering 2024-12-05 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]